Landec (LNDC) Stock Price, News & Analysis

Company Overview

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.

Key Stats

• Today's Range: N/A
• 50-Day Range: $8.05 to $9.95
• 52-Week Range: N/A
• Volume: 1,739 shs
• Average Volume: 84,032 shs
• Market Capitalization: $259.26 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LNDC Stock Analysis - Frequently Asked Questions

How were Landec's earnings last quarter?

Landec Co. (NASDAQ:LNDC) announced its quarterly earnings results on Tuesday, September, 28th. The basic materials company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.11) by $0.12. The basic materials company earned $128.79 million during the quarter, compared to analyst estimates of $128.25 million. Landec had a negative net margin of 36.49% and a negative trailing twelve-month return on equity of 16.79%.

Does Landec have any subsidiaries?

Landec subsidiaries include Yucatan Foods, O Olive Oil, GreenLine Holding, Lifecore, Heartland Hybrids, Apio, Dock Resins, and Curation Foods Inc..

What other stocks do shareholders of Landec own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Landec investors own include Honda Motor (HMC), Comerica (CMA), Walt Disney (DIS), General Mills (GIS), Exxon Mobil (XOM), Cenovus Energy (CVE) and Intel (INTC).

Company Calendar

• Last Earnings: 9/28/2021
• Today: 8/02/2025
• Fiscal Year End: 5/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Specialty Chemicals
• Current Symbol: NASDAQ:LNDC
• CIK: 1005286
• Web: www.landec.com
• Phone: (650) 306-1650
• Fax: 650-368-9818
• Employees: 905
• Year Founded: 1986

Profitability

• EPS (Trailing Twelve Months): ($3.38)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$97.43 million
• Net Margins: -36.49%
• Pretax Margin: -20.04%
• Return on Equity: -16.79%
• Return on Assets: -6.38%

Debt

• Debt-to-Equity Ratio: 0.99
• Current Ratio: 1.40
• Quick Ratio: 0.63

Sales & Book Value

• Annual Sales: $185.79 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 2.55
• Book Value: $3.66 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 29,596,000
• Free Float: 25,272,000
• Market Cap: $259.26 million
• Optionable: Optionable
• Beta: 1.10